
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
OncoLoop: A Network-Based Precision Cancer Medicine Framework
Alessandro Vasciaveo, Juan Martín Arriaga, Francisca Nunes de Almeida, et al.
Cancer Discovery (2022) Vol. 13, Iss. 2, pp. 386-409
Open Access | Times Cited: 24
Alessandro Vasciaveo, Juan Martín Arriaga, Francisca Nunes de Almeida, et al.
Cancer Discovery (2022) Vol. 13, Iss. 2, pp. 386-409
Open Access | Times Cited: 24
Showing 24 citing articles:
A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
Prabhjot S. Mundi, Filemon S. Dela Cruz, Adina Grunn, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1386-1407
Open Access | Times Cited: 23
Prabhjot S. Mundi, Filemon S. Dela Cruz, Adina Grunn, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1386-1407
Open Access | Times Cited: 23
Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression
Tingting Zhang, Faming Zhao, Yahang Lin, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1065-1080
Open Access | Times Cited: 11
Tingting Zhang, Faming Zhao, Yahang Lin, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1065-1080
Open Access | Times Cited: 11
Network-based elucidation of colon cancer drug resistance mechanisms by phosphoproteomic time-series analysis
George Rosenberger, Wenxue Li, Mikko Turunen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
George Rosenberger, Wenxue Li, Mikko Turunen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Network-Based Methods and Their Applications in Drug Discovery
Zhuohang Yu, Zengrui Wu, Ze Wang, et al.
Journal of Chemical Information and Modeling (2023) Vol. 64, Iss. 1, pp. 57-75
Closed Access | Times Cited: 12
Zhuohang Yu, Zengrui Wu, Ze Wang, et al.
Journal of Chemical Information and Modeling (2023) Vol. 64, Iss. 1, pp. 57-75
Closed Access | Times Cited: 12
A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine
Jessica Kalla, Janette Pfneissl, Theresia Mair, et al.
Cellular Oncology (2024)
Open Access | Times Cited: 4
Jessica Kalla, Janette Pfneissl, Theresia Mair, et al.
Cellular Oncology (2024)
Open Access | Times Cited: 4
Molecular characterization of the sea lamprey retina illuminates the evolutionary origin of retinal cell types
Junqiang Wang, Lin Zhang, Martina Cavallini, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Junqiang Wang, Lin Zhang, Martina Cavallini, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Molecular Characterization of the Sea Lamprey Retina Illuminates the Evolutionary Origin of Retinal Cell Types
Junqiang Wang, Lin Zhang, Martina Cavallini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Junqiang Wang, Lin Zhang, Martina Cavallini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Computer-aided drug discovery strategies for novel therapeutics for prostate cancer leveraging next-generating sequencing data
Weijie Zhang, R. Stephanie Huang
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 7, pp. 841-853
Closed Access | Times Cited: 2
Weijie Zhang, R. Stephanie Huang
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 7, pp. 841-853
Closed Access | Times Cited: 2
Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers
Michael E. Stokes, Alessandro Vasciaveo, Jonnell C. Small, et al.
Cell chemical biology (2023) Vol. 31, Iss. 4, pp. 805-819.e9
Closed Access | Times Cited: 4
Michael E. Stokes, Alessandro Vasciaveo, Jonnell C. Small, et al.
Cell chemical biology (2023) Vol. 31, Iss. 4, pp. 805-819.e9
Closed Access | Times Cited: 4
Network analysis to identify driver genes and combination drugs in brain cancer
Farinaz Roshani, Mobina Ahvar, Ali Ebrahimi
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Farinaz Roshani, Mobina Ahvar, Ali Ebrahimi
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Genetically encoded fluorescent sensors for visualizing polyamine levels, uptake, and distribution
Ryo Tamura, Jialin Chen, Marijke De Jaeger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Ryo Tamura, Jialin Chen, Marijke De Jaeger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection
Pasquale Laise, Megan L. Stanifer, Gideon Bosker, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 6
Pasquale Laise, Megan L. Stanifer, Gideon Bosker, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 6
Advances in Making Cancer Mouse Models More Accessible and Informative through Non-Germline Genetic Engineering
Katherine Murphy, Marcus Ruscetti
Cold Spring Harbor Perspectives in Medicine (2023) Vol. 14, Iss. 4, pp. a041348-a041348
Closed Access | Times Cited: 2
Katherine Murphy, Marcus Ruscetti
Cold Spring Harbor Perspectives in Medicine (2023) Vol. 14, Iss. 4, pp. a041348-a041348
Closed Access | Times Cited: 2
Elucidation and Pharmacologic Targeting of Master Regulator Dependencies in Coexisting Diffuse Midline Glioma Subpopulations
Ester Calvo Fernández, Lorenzo Tomassoni, Xu Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ester Calvo Fernández, Lorenzo Tomassoni, Xu Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
pyVIPER: A fast and scalable Python package for rank-based enrichment analysis of single-cell RNASeq data
Alexander L.E. Wang, Zizhao Lin, Luca Zanella, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alexander L.E. Wang, Zizhao Lin, Luca Zanella, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer
Francisca Nunes de Almeida, Alessandro Vasciaveo, Ainsley Mike Antao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Francisca Nunes de Almeida, Alessandro Vasciaveo, Ainsley Mike Antao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identification and Targeting of Regulators of SARS-CoV-2-Host Interactions in the Airway Epithelium.
Brooke Dirvin, Heeju Noh, Lorenzo Tomassoni, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Brooke Dirvin, Heeju Noh, Lorenzo Tomassoni, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identification and Targeting of Regulators of SARS-CoV-2-Host Interactions in the Airway Epithelium.
Brooke Dirvin, Heeju Noh, Lorenzo Tomassoni, et al.
Research Square (Research Square) (2024)
Open Access
Brooke Dirvin, Heeju Noh, Lorenzo Tomassoni, et al.
Research Square (Research Square) (2024)
Open Access
Prostate Luminal Cell Plasticity and Cancer
Emily C. Williams, Maho Shibata
Cancer Letters (2024), pp. 217430-217430
Closed Access
Emily C. Williams, Maho Shibata
Cancer Letters (2024), pp. 217430-217430
Closed Access
ERG-driven prostate cancer emerges from basal-luminal hybrid cells
Weiran Feng, Erik Ladewig, Nazifa Salsabeel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Weiran Feng, Erik Ladewig, Nazifa Salsabeel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Elucidating Compound Mechanism of Action and Polypharmacology with a Large-scale Perturbational Profile Compendium
Lucas Zhongming Hu, Eugene F. Douglass, Mikko Turunen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Lucas Zhongming Hu, Eugene F. Douglass, Mikko Turunen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Epigenetic mechanism of therapeutic resistance and potential of epigenetic therapeutics in chemorefractory prostate cancer
Priti Roy, Kamaleshwar P. Singh
International review of cell and molecular biology (2023), pp. 173-210
Closed Access
Priti Roy, Kamaleshwar P. Singh
International review of cell and molecular biology (2023), pp. 173-210
Closed Access
Systematic Pan-cancer Functional Inference and Validation of Hyper, Hypo and Neomorphic Mutations
Somnath Tagore, Samuel C. S. Tsang, Gordon B. Mills, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Somnath Tagore, Samuel C. S. Tsang, Gordon B. Mills, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy
Jeremy Worley, Heeju Noh, Daoqi You, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Jeremy Worley, Heeju Noh, Daoqi You, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access